Literature DB >> 24617554

Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.

Henna Wong1, David Keeling.   

Abstract

Entities:  

Keywords:  FEIBA; anticoagulation; dabigatran

Mesh：

Substances：

Year:  2014        PMID： 24617554     DOI： 10.1111/bjh.12831

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Authors:  Maureane Hoffman; Joshua N Goldstein; Jerrold H Levy
Journal:  Int J Emerg Med       Date:  2018-12-03

2.  Emergency reversal of dabigatran for emergency surgery.

Authors:  Thomas Puttick; Rahul Bahl; Hussein Mohamedbhai
Journal:  BMJ Case Rep       Date:  2015-04-29

Review 3.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 4.  [Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Authors:  H M Hoffmeister; H Darius; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-04       Impact factor: 0.840

5.  The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.

Authors:  Jamil R Dibu; Jonathan M Weimer; Christine Ahrens; Edward Manno; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

6.  The new era of anticoagulation.

Authors:  Zafia Anklesaria; Georges Al-Helou
Journal:  Surg Neurol Int       Date:  2016-02-19

Review 7.  Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Authors:  Ka-Shing Cheung; Wai K Leung
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

8.  Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial.

Authors:  Valerie A Sera; Ann E Stevens; Howard K Song; Victor M Rodriguez; Frederick A Tibayan; Miriam M Treggiari
Journal:  Pilot Feasibility Stud       Date:  2021-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.